EAM

Exome Asset Management Portfolio holdings

AUM $202M
1-Year Est. Return 151.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+151.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$202M
AUM Growth
+$51M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1 +$5.81M
2 +$4.8M
3 +$4.43M
4
WVE icon
Wave Life Sciences
WVE
+$4.28M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.06M

Top Sells

1 +$8.17M
2 +$4.16M
3 +$4.02M
4
COGT icon
Cogent Biosciences
COGT
+$3.88M
5
APGE icon
Apogee Therapeutics
APGE
+$3.75M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$8.65B
$17.1M 8.46%
58,122
-43,874
COGT icon
2
Cogent Biosciences
COGT
$6.08B
$10.9M 5.36%
305,568
-137,979
GH icon
3
Guardant Health
GH
$12.1B
$10M 4.95%
98,182
IONS icon
4
Ionis Pharmaceuticals
IONS
$12.4B
$9.22M 4.55%
116,515
-14,501
LLY icon
5
Eli Lilly
LLY
$878B
$8.44M 4.17%
7,852
CYTK icon
6
Cytokinetics
CYTK
$7.6B
$7.93M 3.92%
124,749
-17,668
WVE icon
7
Wave Life Sciences
WVE
$2.48B
$7.17M 3.54%
+421,488
VERA icon
8
Vera Therapeutics
VERA
$2.77B
$6.3M 3.11%
124,391
-31,681
BBIO icon
9
BridgeBio Pharma
BBIO
$12.8B
$6.17M 3.05%
80,723
-52,364
ELV icon
10
Elevance Health
ELV
$63.2B
$6.03M 2.98%
+17,191
AZN icon
11
AstraZeneca
AZN
$306B
$5.26M 2.6%
28,362
JAZZ icon
12
Jazz Pharmaceuticals
JAZZ
$11.3B
$4.5M 2.23%
+26,494
NTRA icon
13
Natera
NTRA
$27.9B
$4.27M 2.11%
18,650
IMVT icon
14
Immunovant
IMVT
$5.44B
$4.03M 1.99%
158,622
UHS icon
15
Universal Health Services
UHS
$12B
$3.84M 1.9%
17,628
+9,673
UTHR icon
16
United Therapeutics
UTHR
$21.3B
$3.74M 1.85%
7,685
+1,040
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.62B
$3.73M 1.84%
+136,942
IRON icon
18
Disc Medicine
IRON
$2.3B
$3.71M 1.83%
46,743
-14,613
ISRG icon
19
Intuitive Surgical
ISRG
$176B
$3.6M 1.78%
6,358
GKOS icon
20
Glaukos
GKOS
$6.51B
$3.55M 1.76%
31,471
+4,328
ELVN icon
21
Enliven Therapeutics
ELVN
$1.74B
$3.42M 1.69%
+222,308
CELC icon
22
Celcuity
CELC
$5.33B
$3.42M 1.69%
+34,289
APLS icon
23
Apellis Pharmaceuticals
APLS
$2.58B
$3.41M 1.69%
+135,849
TVTX icon
24
Travere Therapeutics
TVTX
$2.52B
$3.4M 1.68%
89,052
-67,865
DXCM icon
25
DexCom
DXCM
$27.2B
$3.33M 1.64%
+50,147